PharmaDerm

IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere

Applications continued to roll in to FDA while the agency started out the year on a quiet note, with no new major approvals. The agency did, however, name two products that treat rare genetic diseases

IN VITRO DIAGNOSTICS Mergers & Acquisitions Danaher Corp. Beckman Coulter Inc. Siemens AG Siemens Healthcare Diagnostics Inc. Danaher Corp.’s Beckman Coulter Inc. bought Siemens Healthcare Diagnostics

BEIJING – Shangdong-based Luye Pharma Group Ltd. recently completed Phase II trials in the U.S. for its lead compound, cholesterol agent and traditional Chinese medicine Xuezhikang . Xuezhikang’s